Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Analysis of SHIP1 expression and activity in Crohn's disease patients.

Somasundaram R, Fernandes S, Deuring JJ, de Haar C, Kuipers EJ, Vogelaar L, Middleton FA, van der Woude CJ, Peppelenbosch MP, Kerr WG, Fuhler GM.

PLoS One. 2017 Aug 2;12(8):e0182308. doi: 10.1371/journal.pone.0182308. eCollection 2017.

2.

Dichotomal effect of space flight-associated microgravity on stress-activated protein kinases in innate immunity.

Verhaar AP, Hoekstra E, Tjon AS, Utomo WK, Deuring JJ, Bakker ER, Muncan V, Peppelenbosch MP.

Sci Rep. 2014 Jun 27;4:5468. doi: 10.1038/srep05468.

3.

Suppression of p21Rac signaling and increased innate immunity mediate remission in Crohn's disease.

Parikh K, Zhou L, Somasundaram R, Fuhler GM, Deuring JJ, Blokzijl T, Regeling A, Kuipers EJ, Weersma RK, Nuij VJ, Alves M, Vogelaar L, Visser L, de Haar C, Krishnadath KK, van der Woude CJ, Dijkstra G, Faber KN, Peppelenbosch MP.

Sci Transl Med. 2014 Apr 23;6(233):233ra53. doi: 10.1126/scitranslmed.3006763.

4.

Genomic ATG16L1 risk allele-restricted Paneth cell ER stress in quiescent Crohn's disease.

Deuring JJ, Fuhler GM, Konstantinov SR, Peppelenbosch MP, Kuipers EJ, de Haar C, van der Woude CJ.

Gut. 2014 Jul;63(7):1081-91. doi: 10.1136/gutjnl-2012-303527. Epub 2013 Aug 20.

PMID:
23964099
5.

The cell biology of the intestinal epithelium and its relation to inflammatory bowel disease.

Deuring JJ, de Haar C, Kuipers EJ, Peppelenbosch MP, van der Woude CJ.

Int J Biochem Cell Biol. 2013 Apr;45(4):798-806. doi: 10.1016/j.biocel.2012.12.020. Epub 2013 Jan 3. Review.

PMID:
23291352
6.

STAT1, STAT6 and adenosine 3',5'-cyclic monophosphate (cAMP) signaling drive SOCS3 expression in inactive ulcerative colitis.

Li Y, Deuring J, Peppelenbosch MP, Kuipers EJ, de Haar C, van der Woude CJ.

Mol Med. 2012 Dec 20;18:1412-9. doi: 10.2119/molmed.2012.00277.

7.

IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer.

Li Y, Deuring J, Peppelenbosch MP, Kuipers EJ, de Haar C, van der Woude CJ.

Carcinogenesis. 2012 Oct;33(10):1889-96. doi: 10.1093/carcin/bgs214. Epub 2012 Jun 27.

PMID:
22739025
8.

Linking risk conferring mutations in NCF4 to functional consequences in Crohn's disease.

Somasundaram R, Deuring JJ, van der Woude CJ, Peppelenbosch MP, Fuhler GM.

Gut. 2012 Jul;61(7):1097; author reply 1097-8. doi: 10.1136/gutjnl-2011-301344. Epub 2011 Oct 24. No abstract available.

PMID:
22027479
9.

Absence of ABCG2-mediated mucosal detoxification in patients with active inflammatory bowel disease is due to impeded protein folding.

Deuring JJ, de Haar C, Koelewijn CL, Kuipers EJ, Peppelenbosch MP, van der Woude CJ.

Biochem J. 2012 Jan 1;441(1):87-93. doi: 10.1042/BJ20111281.

PMID:
21864296
10.

Impeded protein folding and function in active inflammatory bowel disease.

Deuring JJ, Peppelenbosch MP, Kuipers EJ, van der Woude CJ, de Haar C.

Biochem Soc Trans. 2011 Aug;39(4):1107-11. doi: 10.1042/BST0391107. Review.

PMID:
21787357
11.

Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.

Li Y, de Haar C, Chen M, Deuring J, Gerrits MM, Smits R, Xia B, Kuipers EJ, van der Woude CJ.

Gut. 2010 Feb;59(2):227-35. doi: 10.1136/gut.2009.184176. Epub 2009 Nov 18.

PMID:
19926618

Supplemental Content

Loading ...
Support Center